Fortimedix Surgical news

Fortimedix advances a differentiated symphonX™ ENT product line

“The field of ENT surgery is rapidly evolving,” said Dr. Califano. “The development of more robust, nimble, and affordable single-port systems is accelerating. This trend will help surgeons improve overall patient care and value.”

“Thanks to our expertise in design and development and the robustness of our symphonX™ platform technology, we were able to deliver dedicated ENT instruments within four months of initial prototyping. This again emphasizes the great innovation and execution power of our company.” shared Wout Bijker, CEO at Fortimedix Surgical.

Related:
Go to the News Index

By using our website you consent to all cookies in accordance with our Cookie Policy.